Faculty

Back to Index
Robert Holloway, MD
Assistant Professor of Clinical Psychiatry & The Behavioral Sciences and Pediatrics
Pediatrics
CHLA 4650 W. Sunset Blvd. Off Campus Los Angeles

Publications

The lack of documentation of preferences in a cohort of adults who died after ischemic stroke. Neurology. 2016 May 31; 86(22):2056-62. View in: PubMed

Neurologists as primary palliative care providers: Communication and practice approaches. Neurol Clin Pract. 2016 Feb; 6(1):40-48. View in: PubMed

Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites. Mov Disord. 2014 Nov; 29(13):1666-74. View in: PubMed

Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage. Stroke. 2014 Nov; 45(11):3243-50. View in: PubMed

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease. Mov Disord. 2014 Feb; 29(2):169-76. View in: PubMed

Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord. 2012 Sep 15; 27(11):1398-403. View in: PubMed

Sham surgery controls in Parkinson's disease clinical trials: views of participants. Mov Disord. 2012 Sep 15; 27(11):1461-5. View in: PubMed

Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Mov Disord. 2012 Apr; 27(4):506-11. View in: PubMed

Patient and organizational factors related to education and support use by Veterans with Parkinson's disease. Mov Disord. 2009 Oct 15; 24(13):1916-24. View in: PubMed

Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt). 2009 Sep; 18(9):1355-60. View in: PubMed

Funding of Parkinson research from industry and US federal and foundation sources. Mov Disord. 2009 Apr 15; 24(5):731-7. View in: PubMed

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. View in: PubMed

Ethics of sham surgery: perspective of patients. Mov Disord. 2008 Jan; 23(1):63-8. View in: PubMed

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 Jul 10; 69(2):187-95. View in: PubMed

Health care costs decline after successful epilepsy surgery. Neurology. 2007 Apr 17; 68(16):1290-8. View in: PubMed

Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord. 2007 Mar 15; 22(4):509-14. View in: PubMed

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7. View in: PubMed

Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar; 21(3):362-72. View in: PubMed

Noyes K, Dick AW, Holloway RG. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38. View in: PubMed

Noyes K, Dick AW, Holloway RG. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38. View in: PubMed

Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85. View in: PubMed

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004 Sep; 19(9):1020-8. View in: PubMed

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53. View in: PubMed

Development and testing of the Parkinson's disease quality of life scale. Mov Disord. 2003 Jun; 18(6):637-45. View in: PubMed

Neurologists' use of ICD-9CM codes for dementia. Neurology. 2001 May 8; 56(9):1206-9. View in: PubMed

Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions. Mov Disord. 2000 May; 15(3):439-45. View in: PubMed

Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995. Arch Neurol. 1998 Jan; 55(1):25-32. View in: PubMed

Powered bySC CTSI